Risk of TB among HIV-positive people in high-income countries

The widespread availability of potent combination anti-HIV therapy (commonly called ART or HAART) has greatly reduced deaths from many AIDS-related infections in Canada and other high-income countries. ART does this by suppressing the production of HIV, which in turn allows the immune system to begin to repair itself. The beneficial effects of ART are so profound that researchers increasingly expect that a young HIV-positive adult who starts therapy today should have a near-normal life span, provided that they are engaged with their care and treatment and have minimal pre-existing health conditions.